NetraMark and CAMH Announce Research Award to Advance AI-Driven Discovery in Schizophrenia and Depression
Globenewswire·2025-12-16 13:30
TORONTO, Dec. 16, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced alongside the Centre for Addiction and Mental Health (CAMH) in Toronto, one of the world’s leading mental-health research hospitals, that they have been named recipients of the prestigious Ontario Research Fun ...